Urgent

Neonatal cholestasis / conjugated hyperbilirubinaemia (biliary atresia red flags)

Pale stool, dark urine < 60 days · Paediatric
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Conjugated (direct) hyperbilirubinaemia — direct bilirubin >17-25 micromol/L or >20% of total — is always pathological and defines neonatal cholestasis. The must-not-miss diagnosis is biliary atresia, where a Kasai portoenterostomy performed before ~60 days of life markedly improves outcome, so any jaundice persisting beyond 14 days (21 days if preterm) needs a split bilirubin.

Red flags

  • Persistently pale/acholic stools and dark urine
  • Jaundice beyond 14 days without a split bilirubin checked
  • Hepatomegaly, ascites or coagulopathy
  • Failure to thrive
  • Age approaching 60 days without a diagnosis in suspected biliary atresia

Assessment

Differential diagnosis

  • Biliary atresia
  • Neonatal (idiopathic) hepatitis / infectious hepatitis
  • Choledochal cyst
  • Alpha-1-antitrypsin deficiency
  • Galactosaemia / other metabolic disease
  • TPN-associated cholestasis
  • Alagille syndrome / progressive familial intrahepatic cholestasis

Investigations

  • Split (conjugated and unconjugated) serum bilirubin — the key test for prolonged jaundice
  • LFTs including GGT, albumin, and coagulation (PT/INR)
  • Fasting/serial stool colour assessment with stool colour chart
  • Liver ultrasound (absent/contracted gallbladder, triangular cord sign, choledochal cyst)
  • Alpha-1-antitrypsin level/phenotype, TSH/T4, galactosaemia screen, metabolic and infection screen
  • HIDA scan and/or liver biopsy and intraoperative cholangiogram where indicated

Management

  • Request a split bilirubin on any infant jaundiced beyond 14 days (21 days if preterm)
  • Confirm conjugated fraction and document stool and urine colour
  • Check and correct coagulation — give IV vitamin K for any coagulopathy
  • Send the full cholestasis panel (infective, metabolic, endocrine, genetic) without delay
  • Arrange a fasting liver ultrasound reviewed by a paediatric radiologist
  • Refer urgently to a paediatric hepatology/surgical centre — do not wait for all results if biliary atresia possible
  • Start fat-soluble vitamin supplementation (A, D, E, K) and consider MCT-based feeds
  • Treat any identified cause (e.g. remove lactose for galactosaemia, antivirals for HSV)
  • Proceed to intraoperative cholangiogram and Kasai if biliary atresia confirmed, ideally before 60 days
  • Monitor growth, nutrition and for progression to cirrhosis/portal hypertension

Drugs & doses

Vitamin K (phytomenadione) IV for coagulopathy (e.g. 1 mg IV, repeat per INR response)
Fat-soluble vitamin supplements A, D, E and K at cholestasis-adjusted doses
Ursodeoxycholic acid 10-20 mg/kg/day PO in divided doses (choleretic, cause-dependent)
Cause-specific therapy (e.g. IV aciclovir for HSV; lactose-free feed for galactosaemia)

Disposition

Urgent referral to specialist paediatric liver centre; admit for expedited work-up if biliary atresia suspected. Lifelong hepatology follow-up.

Complications & pitfalls

  • Cirrhosis and portal hypertension
  • Vitamin K-dependent bleeding
  • Fat-soluble vitamin deficiency and failure to thrive
  • Need for liver transplantation
  • Sepsis/cholangitis after Kasai

Exam pearls

  • Conjugated jaundice is NEVER physiological — always investigate
  • The single highest-yield action is a split bilirubin on prolonged jaundice
  • Kasai success falls sharply after ~8 weeks of age — refer early, investigate in parallel
  • Pale stools + dark urine + hepatomegaly are the biliary atresia triad

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.